United Therapeutics CorpAdd to My Watchlist

UTHR:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 119.64
  • 5.04  4.40%
    Today's Change
  • 114.60
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 9/25/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding43 million
Market Cap$5 billion
Return on Equity ttm21.85%
Last DividendUTHR:US does not pay a dividend
EPS: Year Actual ttm14.317
EPS: Year Est. 12/17 ttm13.530
EPS: Quarterly Actual 6/17 4.37
EPS: Quarterly Est. 9/17 4.10
Price/Earnings ttm8.36
Relative Price/Earnings0.390
Earnings Growth Rate14.96
Company Description
United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously.
Revenue$2 billion
Net Income$714 million
Total Assets$2 billion
Web Sitewww.unither.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!